
4th Annual Cardiovascular Conference: Advances in Cardiovascular Disease - from Prevention to Intervention
GLP-1 Agonists: A Review of Within Class Differences for CVD Risk Reduction
April 20, 2021
Login to view comments.
Click here to Login
Session 3